ArticleGigaScience2025
GTestimate: improving relative gene expression estimation in scRNA-seq using the Good-Turing estimator.
Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- scDenorm: a denormalization tool for integrating single-cell transcriptomics data.GigaScience · 2026Article
- Transcriptomic profile of embryoid bodies under hypoxia at single cell level.GigaByte (Hong Kong, China) · 2026Article
- GTestimate: improving relative gene expression estimation in scRNA-seq using the Good-Turing estimator.GigaScience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundSingle-cell RNA-seq suffers from unwanted technical variation between cells, caused by its complex experiments and shallow sequencing depths. Many conventional normalization methods try to remove this variation by calculating the relative gene expression per cell. However, their choice of the maximum likelihood estimator is not ideal for this application.
resultsWe present GTestimate, a new normalization method based on the Good-Turing estimator, which improves upon conventional normalization methods by accounting for unobserved genes. To validate GTestimate, we developed a novel cell-targeted PCR amplification approach (cta-seq), which enables ultra-deep sequencing of single cells. Based on these data, we show that the Good-Turing estimator improves relative gene expression estimation and cell-cell distance estimation. Finally, we use GTestimate's compatibility with Seurat workflows to explore 4 example datasets and show how it can improve downstream results.
conclusionBy choosing a more suitable estimator for the relative gene expression per cell, we were able to improve scRNA-seq normalization, with potentially large implications for downstream results. GTestimate is available as an easy-to-use R-package and compatible with a variety of workflows, which should enable widespread adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.